Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle

Retrovirology

Volumn 12, Issue 1, 2015, Pages

  Bai, Lanlan ^a,b   Otsuki, Hiroyuki ^a   Sato, Hirotaka ^a   Kohara, Junko ^c   Isogai, Emiko ^b   Takeshima, Shin nosuke ^a   Aida, Yoko ^a  

^a RIKEN   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c HOKKAIDO RESEARCH ORGANIZATION   (Japan)

Author keywords

Antibody binding site; Bovine leukemia virus; Bovine leukocyte antigen class II; Common B cell epitope; Comprehensive screening; Peptide ELISA high throughput system; Peptide microarray

Indexed keywords

BOVINE LEUKOCYTE ANTIGEN II DRB3; EPITOPE; GAG PROTEIN; GLYCOPROTEIN GP 51; HLA DR3 ANTIGEN; LEUKOCYTE ANTIGEN; MUTANT PROTEIN; PROTEIN P12; PROTEIN P15; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; ALANINE; BOLA-DRB3 ANTIGEN; HLA ANTIGEN CLASS 2; PEPTIDE; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY COMBINING SITE; ARTICLE; BOVINE; BOVINE LEUKEMIA VIRUS; CONTROLLED STUDY; ENZOOTIC BOVINE LEUKOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH THROUGHPUT SCREENING; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REVERSE GENETICS; SYNCYTIUM; TRANSIENT EXPRESSION; ALLELE; ANIMAL; BINDING SITE; CHEMISTRY; GENETICS; IMMUNOLOGY; MUTATION; SYNTHESIS; VIROLOGY;

ALANINE; ALLELES; ANIMALS; ANTIGENS, VIRAL; BINDING SITES; CATTLE; ENZOOTIC BOVINE LEUKOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; GENE PRODUCTS, GAG; HIGH-THROUGHPUT SCREENING ASSAYS; HISTOCOMPATIBILITY ANTIGENS CLASS II; LEUKEMIA VIRUS, BOVINE; MUTATION; PEPTIDES; PROTEIN ARRAY ANALYSIS; VIRAL ENVELOPE PROTEINS;

EID: 84951972759     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-015-0233-x     Document Type: Article

References (61)

1. Aida Y, Murakami H, Takahashi M, Takeshima SN. Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus. Front Microbiol. 2013;4:328.
2. Burny A, Cleuter Y, Kettmann R, Mammerickx M, Marbaix G, Portetelle D, van den Broeke A, Willems L, Thomas R. Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Vet Microbiol. 1988;17:197-218.
3. Gillet N, Florins A, Boxus M, Burteau C, Nigro A, Vandermeers F, Balon H, Bouzar AB, Defoiche J, Burny A, et al. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology. 2007;4:18.
4. Ott SL, Johnson R, Wells SJ. Association between bovine-leukosis virus seroprevalence and herd-level productivity on US dairy farms. Prev Vet Med. 2003;61:249-62.
5. Erskine RJ, Bartlett PC, Byrem TM, Render CL, Febvay C, Houseman JT. Association between bovine leukemia virus, production, and population age in Michigan dairy herds. J Dairy Sci. 2012;95:727-34.
6. Bartlett PC, Norby B, Byrem TM, Parmelee A, Ledergerber JT, Erskine RJ. Bovine leukemia virus and cow longevity in Michigan dairy herds. J Dairy Sci. 2013;96:1591-7.
7. Rhodes JK, Pelzer KD, Johnson YJ, Russek-Cohen E. Comparison of culling rates among dairy cows grouped on the basis of serologic status for bovine leukemia virus. J Am Vet Med Assoc. 2003;223:229-31.
8. Sagata N, Yasunaga T, Ohishi K, Tsuzuku-Kawamura J, Onuma M, Ikawa Y. Comparison of the entire genomes of bovine leukemia virus and human T-cell leukemia virus and characterization of their unidentified open reading frames. EMBO J. 1984;3:3231-7.
9. Sagata N, Yasunaga T, Ogawa Y, Tsuzuku-Kawamura J, Ikawa Y. Bovine leukemia virus: unique structural features of its long terminal repeats and its evolutionary relationship to human T-cell leukemia virus. Proc Natl Acad Sci USA. 1984;81:4741-5.
10. Dube S, Bachman S, Spicer T, Love J, Choi D, Esteban E, Ferrer JF, Poiesz BJ. Degenerate and specific PCR assays for the detection of bovine leukaemia virus and primate T cell leukaemia/lymphoma virus pol DNA and RNA: phylogenetic comparisons of amplified sequences from cattle and primates from around the world. J Gen Virol. 1997;78(Pt 6):1389-98.
11. Hamard-Peron E, Muriaux D. Retroviral matrix and lipids, the intimate interaction. Retrovirology. 2011;8:15.
12. Copeland TD, Morgan MA, Oroszlan S. Complete amino acid sequence of the nucleic acid-binding protein of bovine leukemia virus. FEBS Lett. 1983;156:37-40.
13. Mager A, Masengo R, Mammerickx M, Letesson JJ. T cell proliferative response to bovine leukaemia virus (BLV): identification of T cell epitopes on the major core protein (p24) in BLV-infected cattle with normal haematological values. J Gen Virol. 1994;75(Pt 9):2223-31.
14. Willems L, Kerkhofs P, Attenelle L, Burny A, Portetelle D, Kettmann R. The major homology region of bovine leukaemia virus p24gag is required for virus infectivity in vivo. J Gen Virol. 1997;78(Pt 3):637-40.
15. Katoh I, Yasunaga T, Yoshinaka Y. Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: close relation to the packaging sites of avian, murine, and human retroviruses. J Virol. 1993;67:1830-9.
16. 2 part of the envelope glycoprotein gp51. Virology. 1989;169:27-33.
17. Callebaut I, Voneche V, Mager A, Fumiere O, Krchnak V, Merza M, Zavada J, Mammerickx M, Burny A, Portetelle D. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51. J Virol. 1993;67:5321-7.
18. Voneche V, Portetelle D, Kettmann R, Willems L, Limbach K, Paoletti E, Ruysschaert JM, Burny A, Brasseur R. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc Natl Acad Sci USA. 1992;89:3810-4.
19. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol. 1998;16:593-617.
20. Aida Y, Takeshima SN, Baldwin CL, Kaushik AK. Bovine immunogenetics. In: Dorian JG, Anatoly R, editors. The Genetics of cattle. Wallingford: CABI; 2015: p. 130-152.
21. Lewin HA, Russell GC, Glass EJ. Comparative organization and function of the major histocompatibility complex of domesticated cattle. Immunol Rev. 1999;167:145-58.
22. Juliarena MA, Poli M, Sala L, Ceriani C, Gutierrez S, Dolcini G, Rodriguez EM, Marino B, Rodriguez-Dubra C, Esteban EN. Association of BLV infection profiles with alleles of the BoLA-DRB3.2 gene. Anim Genet. 2008;39:432-8.
23. Mirsky ML, Olmstead C, Da Y, Lewin HA. Reduced bovine leukaemia virus proviral load in genetically resistant cattle. Anim Genet. 1998;29:245-52.
24. Miyasaka T, Takeshima SN, Jimba M, Matsumoto Y, Kobayashi N, Matsuhashi T, Sentsui H, Aida Y. Identification of bovine leukocyte antigen class II haplotypes associated with variations in bovine leukemia virus proviral load in Japanese Black cattle. Tissue Antigens. 2013;81:72-82.
25. Bai L, Takeshima SN, Isogai E, Kohara J, Aida Y. Novel CD8 cytotoxic T cell epitopes in bovine leukemia virus with cattle. Vaccine. 2015;33:7194-9202.
26. Sakakibara N, Kabeya H, Ohashi K, Sugimoto C, Onuma M. Epitope mapping of bovine leukemia virus transactivator protein Tax. J Vet Med Sci. 1998;60:599-605.
27. Kabeya H, Ohashi K, Sugimoto C, Onuma M. Bovine leukaemia virus envelope peptides cause immunomodulation in BALB/c mice. Vet Immunol Immunopathol. 1999;68:39-48.
28. Gatei MH, Good MF, Daniel RC, Lavin MF. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development. J Virol. 1993;67:1796-802.
29. Portetelle D, Dandoy C, Burny A, Zavada J, Siakkou H, Gras-Masse H, Drobecq H, Tartar A. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51. Virology. 1989;169:34-41.
30. Radke K, Grossman D, Kidd LC. Humoral immune response of experimentally infected sheep defines two early periods of bovine leukemia virus replication. Microb Pathog. 1990;9:159-71.
31. Onuma M, Hodatsu T, Yamamoto S, Higashihara M, Masu S, Mikami T, Izawa H. Protection by vaccination against bovine leukemia virus infection in sheep. Am J Vet Res. 1984;45:1212-5.
32. Suneya M, Onuma M, Yamamoto S, Hamada K, Watarai S, Mikami T, Izawa H. Induction of lymphosarcoma in sheep inoculated with bovine leukaemia virus. J Comp Pathol. 1984;94:301-9.
33. Onuma M, Wada M, Yasutomi Y, Yamamoto M, Okada HM, Kawakami Y. Suppression of immunological responses in rabbits experimentally infected with bovine leukemia virus. Vet Microbiol. 1990;25:131-41.
34. Davydov II, Tonevitskii AG. Linear B-cell epitope prediction. Mol Biol (Mosk). 2009;43:166-74.
35. Eichmann K, Rajewsky K. Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol. 1975;5:661-6.
36. Reineke U, Schutkowski M. Epitope mapping protocols. Preface. Methods Mol Biol. 2009;524:v-vi.
37. Inabe K, Ikuta K, Aida Y. Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus. Virology. 1998;245:53-64.
38. Tajima S, Takahashi M, Takeshima SN, Konnai S, Yin SA, Watarai S, Tanaka Y, Onuma M, Okada K, Aida Y. A mutant form of the tax protein of bovine leukemia virus (BLV), with enhanced transactivation activity, increases expression and propagation of BLV in vitro but not in vivo. J Virol. 2003;77:1894-903.
39. Zhu H, Luo H, Yan M, Zuo X, Li QZ. Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus. Genom Proteom Bioinform. 2015;13:210-8.
40. Yakobson B, Brenner J, Ungar-Waron H, Trainin Z. Short-termed expression of interleukin-12 during experimental BLV infection may direct disease progression to persistent lymphocytosis. Vet Immunol Immunopathol. 1998;64:207-18.
41. Rovnak J, Boyd AL, Casey JW, Gonda MA, Jensen WA, Cockerell GL. Pathogenicity of molecularly cloned bovine leukemia virus. J Virol. 1993;67:7096-105.
42. Van Der Maaten MJ, Miller JM. Replication of bovine leukemia virus in monolayer cell cultures. Bibl Haematol. 1975;43:360-2.
43. Gutierrez G, Rodriguez SM, de Brogniez A, Gillet N, Golime R, Burny A, Jaworski JP, Alvarez I, Vagnoni L, Trono K, Willems L. Vaccination against delta-retroviruses: the bovine leukemia virus paradigm. Viruses. 2014;6:2416-27.
44. Rodriguez SM, Florins A, Gillet N, de Brogniez A, Sanchez-Alcaraz MT, Boxus M, Boulanger F, Gutierrez G, Trono K, Alvarez I, et al. Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses. 2011;3:1210-48.
45. Palacios R, Martinez-Maza O, Guy K. Monoclonal antibodies against HLA-DR antigens replace T helper cells in activation of B lymphocytes. Proc Natl Acad Sci USA. 1983;80:3456-60.
46. Mourad W, Scholl P, Diaz A, Geha R, Chatila T. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction. J Exp Med. 1989;170:2011-22.
47. Palker TJ, Riggs ER, Spragion DE, Muir AJ, Scearce RM, Randall RR, McAdams MW, McKnight A, Clapham PR, Weiss RA, et al. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J Virol. 1992;66:5879-89.
48. Callebaut I, Portetelle D, Burny A, Mornon JP. Identification of functional sites on bovine leukemia virus envelope glycoproteins using structural and immunological data. Eur J Biochem. 1994;222:405-14.
49. Johnston ER, Albritton LM, Radke K. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein. J Virol. 2002;76:10861-72.
50. de Brogniez A, Bouzar AB, Jacques JR, Cosse JP, Gillet N, Callebaut I, Reichert M, Willems L. Mutation of a single envelope N-Linked glycosylation site enhances the pathogenicity of bovine leukemia virus. J Virol. 2015;89:8945-56.
51. Jimba M, Takeshima SN, Matoba K, Endoh D, Aida Y. BLV-CoCoMo-qPCR: quantitation of bovine leukemia virus proviral load using the CoCoMo algorithm. Retrovirology. 2010;7:91.
52. Jimba M, Takeshima SN, Murakami H, Kohara J, Kobayashi N, Matsuhashi T, Ohmori T, Nunoya T, Aida Y. BLV-CoCoMo-qPCR: a useful tool for evaluating bovine leukemia virus infection status. BMC Vet Res. 2012;8:167.
53. Takeshima SN, Kitamura-Muramatsu Y, Yuan Y, Polat M, Saito S, Aida Y. BLV-CoCoMo-qPCR-2: improvements to the BLV-CoCoMo-qPCR assay for bovine leukemia virus by reducing primer degeneracy and constructing an optimal standard curve. Arch Virol. 2015;160:1325-32.
54. Polat M, Ohno A, Takeshima SN, Kim J, Kikuya M, Matsumoto Y, Mingala CN, Onuma M, Aida Y. Detection and molecular characterization of bovine leukemia virus in Philippine cattle. Arch Virol. 2015;160:285-96.
55. Takeshima SN, Matsumoto Y, Miyasaka T, Arainga-Ramirez M, Saito H, Onuma M, Aida Y. A new method for typing bovine major histocompatibility complex class II DRB3 alleles by combining two established PCR sequence-based techniques. Tissue Antigens. 2011;78:208-13.
56. Lavinder JJ, Wine Y, Giesecke C, Ippolito GC, Horton AP, Lungu OI, Hoi KH, DeKosky BJ, Murrin EM, Wirth MM, et al. Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc Natl Acad Sci USA. 2014;111:2259-64.
57. Cuccuru MA, Dessi D, Rappelli P, Fiori PL. A simple, rapid and inexpensive technique to bind small peptides to polystyrene surfaces for immunoenzymatic assays. J Immunol Methods. 2012;382:216-9.
58. Inabe K, Nishizawa M, Tajima S, Ikuta K, Aida Y. The YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions. J Virol. 1999;73:1293-301.
59. Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene. 1996;173:33-8.
60. Murakami T, Aida Y. Visualizing Vpr-induced G2 arrest and apoptosis. PLoS One. 2014;9:e86840.
61. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731-9.